Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: Castle Creek Pharmaceuticals (0) Acquired (2)
azficel-T (Laviv) (8 trials)
fcx-007 (2 trials)
Key: Castle Creek Pharmaceuticals (1) Acquired (2)
diacerein (7 trials)
fcx-013 (1 trial)
veledimex (1 trial)
Epidermolysis Bullosa (Phase 3)
Epidermolysis Bullosa Dystrophica (Phase 3)
Epidermolysis Bullosa, Junctional (Phase 1)
Epidermolysis Bullosa Simplex (Phase 2)
Trials (18 total)
Trial APIs (5 total)